Experienced in Xeroderma Pigmentosum

Cheng-jen W. Ma

Kaohsiung, KHQ, TW 
Experienced in Xeroderma Pigmentosum
Kaohsiung, KHQ, TW 
OverviewLocationsClinical Research

Overview

Cheng-jen Ma practices in Kaohsiung, Taiwan. Ma is rated as an Experienced expert by MediFind in the treatment of Xeroderma Pigmentosum. Their top areas of expertise are Colorectal Cancer, Xeroderma Pigmentosum, Stomach Cancer, Malnutrition, and Ileostomy.

Their clinical research consists of co-authoring 64 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Xeroderma Pigmentosum.

Locations

Kaohsiung, KHQ, Taiwan
Other Locations
TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Pilot Study of Home Parenteral Nutrition for Malnourished Patients With Unresectable Stage IV Gastric Receiving Salvage Chemotherapy
A Pilot Study of Home Parenteral Nutrition for Malnourished Patients With Unresectable Stage IV Gastric Receiving Salvage Chemotherapy
Enrollment Status: Completed
Publish Date: June 21, 2019
Intervention Type: Drug, Other
Study Phase: Not Applicable

64 Total Publications

Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only.
Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only.
Journal: Cancer management and research
Published: December 22, 2021

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ma's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile